Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
US Army
Argus Health

Generated: July 24, 2017

DrugPatentWatch Database Preview

Isoproterenol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for isoproterenol hydrochloride and what is the scope of isoproterenol hydrochloride patent protection?

Isoproterenol hydrochloride
is the generic ingredient in six branded drugs marketed by Alpharma Us Pharms, Fisons, Abbott, Hospira, Intl Medication, Sanofi Aventis Us, Abraxis Pharm, Armour Pharm, Parke Davis, Lilly, DEY, 3M, and Baxter Hlthcare, and is included in twenty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for isoproterenol hydrochloride. Three suppliers are listed for this compound.

Summary for Generic Name: isoproterenol hydrochloride

Drug Master File Entries: see list14
Suppliers / Packagers: see list3
Bulk Api Vendors: see list65
Clinical Trials: see list2,264
Patent Applications: see list1,016
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:isoproterenol hydrochloride at DailyMed

Pharmacology for Ingredient: isoproterenol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
isoproterenol hydrochloride
SOLUTION;INHALATION085994-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
isoproterenol hydrochloride
INJECTABLE;INJECTION010515-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
isoproterenol hydrochloride
TABLET;RECTAL, SUBLINGUAL006328-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
isoproterenol hydrochloride
SOLUTION;INHALATION006327-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
isoproterenol hydrochloride; phenylephrine bitartrate
AEROSOL, METERED;INHALATION013296-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Argus Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus